Pharmafile Logo
Pharmafocus logo
Advanced Search
moderna_norwood_plant

Moderna to supply up to 500 million COVID-19 vaccines to COVAX

May 4, 2021
Manufacturing and Production, Sales and Marketing COVAX, COVID-19, Moderna, Vaccine, WHO

Moderna have announced a supply agreement with Gavi, the Vaccine Alliance, for up to 500 million doses of their COVID-19 …

News
Top 10 news roundup

Pharmafile.com’s top 10 news stories of the week

April 30, 2021
Medical Communications COVID-19, covid 19 news, covid-19 news, news roundup, pharma, pharma news

Among our top 10 stories this week: In COVID news, an app has revealed the most common side effects for …

News

Celltrion’s COVID-19 treatment shows promise against South African variant

April 30, 2021
Medical Communications COVID-19, celltrion, covid 19 news, covid-19 news, covid-19 treatment, pharma, pharma news

Celltrion’s regdanvimab treatment for COVID-19 has shown itself to be effective against the South African variant of the virus, according …

News

Melanoma market to reach $7.4bn by 2029

April 30, 2021
Medical Communications melanoma

A report from GlobalData, Melanoma – Global Drug Forecast and Market Analysis to 2029, has predicted the melanoma industry will …

News

Scipher Medicine to expand into autoimmune disease therapeutics

April 30, 2021
Medical Communications AI, autoimmune diseases

Scipher Medicine, a precision immunology company, announced the launch on Scipher Therapeutics on Thursday, marking the company’s shift towards the …

News

Positive phase III results achieved for dialysis drug in China

April 30, 2021
Medical Communications China, Kideny disease

Vifor Fresenius Medical Care Renal Pharma (VFMCRP) today announced positive results from a phase-III study in China (PA-CL-CHINA-01), evaluating the …

News
Takeda building

Takeda’s lung cancer drug granted FDA priority review

April 29, 2021
FDA, Takeda, lung cancer treatment, pharma, pharma news

The FDA has granted priority review for Takeda’s New Drug Application (NDA) for its mobocertinib drug for the treatment of …

News

Pharnext CMT drug shows positive Phase III results

April 29, 2021
CMT, Charcot-Marie-Tooth Disease, Phase III trial, pharma, pharma news, pharnext

Pharnext SA’s PXT3003 treatment for patients with Charcot-Marie-Tooth Disease (CMT) has shown positive interim results in its ongoing Phase III …

News

EC approves Kaftrio as combination treatment for cystic fibrosis

April 29, 2021
EU, European Commission, cystic fibrosis

Vertex Pharmaceuticals has been granted European Commission approval for the label extension of Kaftrio (ivacaftor/tezacaftor/elexacaftor) in a combination regimen with …

News
Bristol Myers Squibb building in New Jersey

Bristol Myers Squibb psoriasis drug shows positive Phase III results

April 29, 2021
Bristol-Myers Squibb, bristol myers squibb, pharma, pharma news, psoriasis, psoriasis treatment

Bristol Myers Squibb’s investigational deucravacitinib drug, for the treatment of moderate-to-severe plaque psoriasis, has shown positive results in two Phase …

News
moderna_norwood_plant

Moderna up investments to produce 3 billion COVID vaccine doses in 2022

April 29, 2021
COVID-19, Moderna, Vaccine, investment

Moderna have announced it is making new funding commitments to increase supply at its owned and partnered manufacturing facilities, which …

News
COVID-19 virus

Pharmafile.com’s weekly COVID-19 news round-up

April 28, 2021
Research and Development COVID-19, covid 19 news, covid-19 news, news roundup, pharma, pharma news

The past week has seen plenty of COVID-19 news continue to roll in: The European Commission has sued AstraZeneca over …

News

COVID Symptom Study app reveals most common vaccine side effects

April 28, 2021
Research and Development COVID-19, Vaccine, data

An analysis of over 600,000 people’s vaccine reports has been published in The Lancet Infectious Diseases journal, in the largest …

News

Calliditas’ kidney disease drug granted priority review by FDA

April 28, 2021
Research and Development Calliditas, FDA, nephropathy, pharma, pharma news

The FDA has granted priority review for the New Drug Applicaton (NDA) for Calliditas Therapeutics’ Nefecon, for the treatment of …

News

NICE to join GetReal Institute alongside nine key healthcare players

April 28, 2021
Research and Development EU, NICE, rwe

NICE has announced it will join with nine other organisations to form the GetReal Institute, a not-for-profit multi-stakeholder enterprise, as …

News

Single dose of COVID vaccine can cut transmissions in half

April 28, 2021
Research and Development COVID-19, Public Health England, Vaccine

A Public Health England (PHE) study into the Pfizer-BioNTech and Oxford-AstraZeneca vaccines has found that a single dose of either …

News
download_2

Sheila Frame new President for the Americas at Amryt

April 27, 2021
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

Biopharmaceutical company Amryt have appointed Sheila Frame as President for the Americas.

Appointment
download_1

Francesco Maria Lavino appointed CEO of F2G Ltd

April 27, 2021
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

F2G Limited has announced that Francesco Maria Lavino has been appointed Chief Executive Officer and member of the Board of …

Appointment
download

Macrogen Europe appoints Dr Bongcho Kim as new CEO

April 27, 2021
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

Macrogen Europe have announced the appointment of a new CEO, Dr Bongcho Kim, who joins the company after a successful …

Appointment

King & Spalding announce appointment of former FDA official

April 27, 2021
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

Eva Temkin, a former senior FDA official for therapeutic biologics and biosimilars, has joined King & Spalding in Washington, US, …

Appointment
The Gateway to Local Adoption Series

Latest content

Five Facts about spinal muscular atrophy

January 28, 2026

Sobi’s Aspaveli receives European Commission approval for treatment of two rare kidney diseases

January 28, 2026

Everdrone appoints David Borkmann as Senior Medical Advisor

January 28, 2026

MRM Health’s ulcerative colitis treatment receives FDA Investigational New Drug clearance

January 27, 2026

Crystalys Therapeutics appoints Justin Thacker as Chief Financial Officer

January 27, 2026